Skip to content

Clinical trials

Phase 2 Dermatomyositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Phase: Phase 2 Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20061
20081
20101
20111
20121
20132
20141
20152
20172
20182
20203
20212
20222
20233
20243
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting6
Terminated5
Withdrawn3
Not yet recruiting2
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)4
Novartis Pharmaceuticals3
Kezar Life Sciences, Inc.2
Pfizer2
Alison Ehrlich1
Assistance Publique - Hôpitaux de Paris1
Chester Oddis1
Corbus Pharmaceuticals Inc.1
EMD Serono Research & Development Institute, Inc.1
Idera Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis40
Polymyositis15
Myositis11
Scleroderma, Systemic3
Arthritis, Juvenile2
Arthritis, Rheumatoid2
Calcinosis2
Lung Diseases, Interstitial2
Lupus Erythematosus, Systemic2
Muscle Weakness2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.